- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2014-003191-23.
Displaying page 1 of 1.
EudraCT Number: 2014-003191-23 | Sponsor Protocol Number: ANZUP1303 | Start Date*: 2014-11-07 | |||||||||||
Sponsor Name:Cancer Trials Ireland | |||||||||||||
Full Title: Randomised phase 3 trial of enzalutamide in androgen deprivation therapy with radiation therapy for high risk, clinically localised, prostate cancer: ENZARAD | |||||||||||||
Medical condition: Localised prostate cancer at high risk of recurrence | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: IE (Trial now transitioned) GB (GB - no longer in EU/EEA) BE (Completed) AT (Trial now transitioned) ES (Ongoing) SI (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
